Capricor Therapeutics (CAPR)
(Delayed Data from NSDQ)
$5.08 USD
+0.67 (15.19%)
Updated Sep 17, 2024 04:00 PM ET
After-Market: $5.15 +0.07 (1.38%) 7:58 PM ET
3-Hold of 5 3
F Value F Growth F Momentum F VGM
Industry / Sector Report
Industry : Medical - Products
Zacks Industry Rank
Top 26% (65 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.00 | 1.70 | 9.99 |
Current Quarter Estimate | -0.34 | 7.55 | 61.00 |
Year Ago Quarter Estimate | -0.25 | 4.52 | 54.84 |
Next Quarter Estimate | -0.33 | 8.55 | 63.00 |
Next Year Estimate | -0.43 | 45.18 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | -49.40 | 14.80 | 15.67 |
Next Year | 65.32 | 22.60 | 11.34 |
Last 5 Years | NA | 2.90 | 8.10 |
Next 5 Years | NA | 15.90 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | NA | 5.81 |
Price/Book (MRQ) | 12.26 | 2.18 |
Price/Cash Flow (MRFY) | NA | 11.77 |
Dividend Yield | 0.00% | 0.00% |
Net Profit Margin (TTM) | -102.93% | -9.36% |
Return on Equity (TTM) | -220.27% | -3.53% |
Debt to Equity (MRQ) | 0.00 | 23.08 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.